ESSENT BIOLOGICS LAUNCHES MICRONIZED BONE MATRIX FOR 3D BIOPRINTING AND TISSUE ENGINEERING APPLICATIONS
Published in Bioprinting.
CENTENNIAL, Colo., Dec. 13, 2022 /PRNewswire/ — Essent Biologics™, a leading supplier of human-derived cell and scaffold materials, today announced availability of its Micronized Bone Matrix (MBM) for 3D bioprinting and tissue engineering applications. Essent Biologics will provide a mineralized allograft bone matrix derived from human ground cortical bone that contains native proteins, such as Collagen Type I, and native elements and minerals, such as calcium and phosphorus.
Providing human scaffolding material provides a ready-made, biologically relevant bioink additive for researchers
With the increased focus on additive manufacturing technologies to advance bone tissue engineering, the demand for biologically relevant scaffolds and bio-ink additives has grown at a steady pace. As an integral part of bone tissue engineering, scaffolds are 3D biocompatible structures which can mimic the ECM properties—including mechanical support and cellular stimulation through biochemical and mechanical interactions—and provide a template for cell attachment to stimulate bone tissue formation.